Question 1

What does Ernexa Therapeutics do?

Accepted Answer

Ernexa Therapeutics is a biopharmaceutical firm in the clinical stages that researches and develops innovative cytokine-based therapies.

Question 2

In what sectors does Ernexa Therapeutics operate?

Accepted Answer

Ernexa Therapeutics operates in Biotechnology, Health Care, Pharmaceutical, Therapeutics.

Question 3

How many companies has Ernexa Therapeutics acquired?

Accepted Answer

Ernexa Therapeutics has made 3 acquisitions between 2018-2021, with a total disclosed deal value of $125.0M.

Question 4

What companies are owned by Ernexa Therapeutics?

Accepted Answer

Companies acquired by Ernexa Therapeutics include NTN Buzztime, Novellus, IRX Therapeutics.

Question 5

What are Ernexa Therapeutics's major acquisitions?

Accepted Answer

Ernexa Therapeutics's largest acquisitions include Novellus ($125.0M, 2021).

Question 6

What is Ernexa Therapeutics's largest acquisition?

Accepted Answer

Ernexa Therapeutics's largest disclosed acquisition is Novellus for $125.0M (2021).

Question 7

What was Ernexa Therapeutics's first acquisition?

Accepted Answer

Ernexa Therapeutics's first recorded acquisition was IRX Therapeutics in 2018.

Question 8

What was Ernexa Therapeutics's most recent acquisition?

Accepted Answer

Ernexa Therapeutics's most recent acquisition is NTN Buzztime, announced August 2021.

Question 9

What is the average deal size for Ernexa Therapeutics acquisitions?

Accepted Answer

The average disclosed deal size for Ernexa Therapeutics acquisitions is $125.0M.

Question 10

What is the median deal size for Ernexa Therapeutics acquisitions?

Accepted Answer

The median disclosed deal size for Ernexa Therapeutics acquisitions is $125.0M. The median is often lower than the average because a few very large deals pull the average up.

Question 11

How much has Ernexa Therapeutics spent on acquisitions?

Accepted Answer

Ernexa Therapeutics has spent at least $125.0M across its disclosed acquisitions (of 3 total deals; some prices are undisclosed).

Question 12

Which sector has Ernexa Therapeutics spent the most on?

Accepted Answer

Ernexa Therapeutics has committed the most disclosed capital to Biotechnology companies — about $125.0M across its deals in that sector.

Question 13

What sectors does Ernexa Therapeutics usually acquire in?

Accepted Answer

Ernexa Therapeutics most frequently acquires companies in Biotechnology, Medical, Advertising.

Question 14

In which sector has Ernexa Therapeutics made the most acquisitions?

Accepted Answer

Ernexa Therapeutics has made the most acquisitions in the Biotechnology sector.

Question 15

In which year did Ernexa Therapeutics make the most acquisitions?

Accepted Answer

Ernexa Therapeutics made the most acquisitions in 2021, with 2 deals.

Datasets

Top Companies

Top Industries

Years (1990-2026)

Ernexa Therapeutics

Company Details

Funding & Financials

Web Traffic

Company Info

Acquisitions by Ernexa Therapeutics

Key People at Ernexa Therapeutics

Explore 200,000+ acquisitions — free

Recent News related to Ernexa Therapeutics

FAQs about Ernexa Therapeutics

People who checked this page also checked these